MiYOSMART eyeglass lenses using DIMS technology, used to slow the progression of myopia in children, show long-term effectiveness and lack of so-called the rebound effect, i.e. the rate of defect progression after discontinuation of their use, does not accelerate – according to the latest clinical studies carried out by the Center for Myopia Research at the Hong Kong Polytechnic University[1]. In Poland, it is the second most popular method of slowing the progression of myopia, the use of which is declared by 31,3% of parents of children with a diagnosed defect, who are aware of the possibility of slowing it down.[2]. In the world, one million children in over 30 countries have used this type of lenses[3].
A pioneering six-year clinical trial on the use of MiYOSMART eyeglass lenses with DIMS technology (Defocus Incorporated Multiple Segments) is the longest-lasting study to date on the effectiveness of eyeglass lenses for the control of myopia. It was carried out in 90 Asian children and was a follow-up to a previous three-year [4] and two-year [5] study showing strong evidence of the effectiveness of these lenses in slowing the progression of myopia in children aged 8-13 years. The results of a six-year study showed that the effect of spectacle lenses in controlling the progression of myopia over time in children wearing these lenses. It has also been confirmed that in patients who have stopped wearing lenses with DIMS technology, there is no so-called rebound effect on baseline myopia progression in a XNUMX-year randomized controlled trial, nor compared to the general population.
For the ever-growing number of children diagnosed with the defect in Poland, the results presented in May 2022 at the Association for Vision Research and Ophthalmology (ARVO) conference [6] held in Denver, Colorado, hope to slow the progression of myopia by an average of 60%. compared to the use of standard single vision lenses [7], thus minimizing the risk of complications and high myopia in the future.
Myopia is the most frequently diagnosed sight defect in children, affecting an increasing number of young patients not only in Poland, but all over the world. Therefore, the fact that the effect of lenses using the DIMS technology in slowing down the progression of myopia lasts over time, and that after discontinuing their use, there is no rebound effect, is great news not only for us, but above all for many thousands of parents and children who have a diagnosis. behind him. – Mowi Sylwia Kijewska, optometrist, Product Manager of Hoya Lens Poland. – The consequences of the rapid progression of myopia in children extend far beyond vision problems. High visual impairment often leads to withdrawal, learning problems, low self-esteem, and networking with peers. That is why it is so important to diagnose it as early as possible and take appropriate actions to not only correct the defect, but also to slow down the defect’s progression. – he adds.
Spectacle lenses with DIMS technology have been described as an effective method of myopia control in the latest guidelines of the Polish Ophthalmology Society regarding the management of the progression of myopia in children and adolescents.
Low parental awareness in Poland
According to a study conducted in March 2022 at the request of Hoya Lens Poland [8], in Poland less than half (47,5%) of parents of children diagnosed with myopia have heard about the concept of myopia control, or know that the defect progression can be slow down.
70% of parents of children diagnosed with myopia who have never heard of the possibility of slowing the development of the defect declare that they would consider using such methods if they knew about them. That is why it is so important to make Poles aware of this topic. Myopia is not a sentence. The sooner we act, the greater the chance of avoiding serious problems in the future. – he comments Sylwia Kijewska.
Among the methods of myopia control, apart from MiYOSMART lenses, there are, among others: orthokeratological contact lenses worn at night, eye drops with low concentration of atropine and specialized, soft contact lenses. In this combination, eyeglass lenses using DIMS technology are a non-invasive and safe solution that not only improves visual acuity, but also slows down the defect’s progression.
Launched in 2018, MiYOSMART eyeglass lenses with DIMS technology were developed in collaboration with the Hong Kong University of Technology to control the progression of myopia, an increasing global health problem, and industry experts predict it will be there by 2050. affect almost 50% of the world’s population [9]. The lens provides children with sharp vision and slows down the progression of the visual defect, while being the same as a standard monofocal spectacle lens.
MiYOSMART eyeglass lenses can only be recommended by certified eye care professionals and are only available in certified opticians’ salons. The list of certified specialists is available at www.mamwzrokok.pl
[1] Lam CS, et al. Myopia control in chiIdren wearing DIMS spectacle lens: 6 years results. Invest Ophthalmol Vis Sci. 2022;63:ARVO E-Abstract 4247
[2] A study by the research agency SW Research in March 2022, on the knowledge of the control of myopia in children. As part of the study, 600 online interviews were conducted with parents of children with myopia.
[3] Based on the number of lenses sold by Hoya – sales data as of February 2022.
[4] Lam CSY, Tang WC, Lee PH i wsp., Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study. British Journal of Ophthalmology Pierwsza publikacja online: 17 marca 2021 r. doi: 10.1136/bjophthalmol-2020-317664
[5] Lam CSY, Tang WC, Tse DY, Lee RPK, Chun RKM, Hasegawa K, Qi H, Hatanaka T, To CH. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomized clinical trial. British Journal of Ophthalmology. Pierwsza publikacja online: 29 May 2019. doi: 10.1136/bjophthalmol-2018-313739
[6] Association for Research in Vision and Ophthalmology, ARVO
[7] Lam CSY, Tang WC, Tse DY, Lee RPK, Chun RKM, Hasegawa K, Qi H, Hatanaka T, To CH. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomized clinical trial. British Journal of Ophthalmology. Pierwsza publikacja online: 29 May 2019. doi: 10.1136/bjophthalmol-2018-313739
[8] A study by the research agency SW Research in March 2022, on the knowledge of the control of myopia in children. As part of the study, 600 online interviews were conducted with parents of children with myopia.
[9] Holden B.A., Fricke T.R., Wilson D.A., Jong M., Naidoo K.S., Sankaridurg P., Wong T.Y., Naduvilath T.J., Resniko_ S. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Amerykańska Akademia Okulistyczna (American Academy of Ophthalmology) 05/2016, vol. 123, nr 5, strony 1036–1042.
Sponsored article